ArticleBlood cancer journal2026

Olverembatinib plus immunotherapy versus olverembatinib plus allogeneic hematopoietic cell transplantation in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Chenying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.